Verde Media Group Inc. CEO, William Veve, Interviewed Live

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Verde Media Group Inc. CEO, William Veve, Interviewed Live on ABC Radio's "The Amilya Show" to Introduce BeautyJect Inc.

NEW YORK, July 23, 2014 (GLOBE NEWSWIRE) -- Verde Media Group Inc. (OTC:VMGI) is an emerging growth biotechnology company. Through its subsidiary, Beautyject Inc., it will provide needle-free injectable devices with a unique patented technology and design. Verde Media CEO, William Veve introduced the product prior to its official launch in North and South American markets during the months to come. Mr. Veve was interviewed live by host Amilya Antonetti on ABC Talk Radio's "The Amilya Show."

The cosmetic needle-free products will be marketed in clinical form for professionals. However, the company is looking to its over-the-counter delivery system for consumer use as its most lucrative product line. Boutique marketing firm, Power Shark Capital, advised by Kevin Harrington from ABC's series, "Shark Tank," will be orchestrating the official large-scale release of the product as well as sales and distribution functions in conjunction with Verde. 

In the exclusive interview, Mr. Veve discussed the company's subsidiary BeautyJect, Inc., commenting specifically, "on its new needle-free, over-the-counter cosmetic injectable devices and needle-free syringes."  The interview also delved into the application of these products and the feedback expected by healthcare communities embracing the introduction of needle-free devices.

"The Amilya Show" radio broadcast has a wide reach and represented a unique opportunity to pre-release the product from the VMGI subsidiary, Beautyject Inc. ABC / Cumulus Radio reaches 150 million monthly listeners and serves 110 cities through 525 radio stations in the U.S. alone. 77WABC-AM in New York is the most-listened-to talk radio station in the country.

"It's an exciting time for the company as we're poised to release what will certainly be a well-received and anticipated technological advancement for over-the-counter cosmetics," said VMGI CEO, William Veve. "This exposure on 'The Amilya Show' is a great way to introduce the product before our major release through Power Shark Capital in the coming months."

About Cumulus Radio:

Cumulus is the nation's second largest operator of radio stations in America with 150 million monthly listeners. It serves 110 cities through 525 owned radio stations in the U.S., www.Cumulus.com

About 77WABC | WABC:

77WABC-AM is a broadcast radio station in New York City, providing News and Talk programs. Established in 1921, WABC is one of the longest broadcasting stations in the country. From its heyday as the pioneer of "Top 40" radio, to its success as the most-listened-to talk radio station in the country, WABC continues to reflect the spirit, energy, and excitement that is New York.

About Amilya Antonetti:

Amilya Antonetti is a world-renowned news correspondent, CEO and host of the "The Amilya Show" on ABC Radio, a Cumulus station.

For the past 20 years Amilya has captured media attention nationally on networks and shows such as; Oprah, Fox News, CNBC, Dr. Phil and Good Morning Arizona. Her wit combined with street smarts and a "straight shooter" interviewing style allows both her guests and the audience to participate in an honest conversation.

Tune in live weekly at 77WABC-AM Saturdays from 1-3pm ET to hear the latest in Business, Leadership, Lifestyle & Market Trends and the inside-scoop on what is really happening with women-in-business. To learn more, visit www.amilya.com .

The 77WABC Pod Cast of the show can be heard by following this link: http://bit.ly/1rK4VlS

About Verde Media Group Inc.

Verde Media Group Inc. is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI. Verde Media Group Inc.  The company consists of three divisions:

Agency Division - The innovative Agency division services- public relations, marketing, and transaction functions for corporate clientele.

BioTech Division - The Biotech Division manages a portfolio of biotech companies and the VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass.  The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock.  

Entertainment Division - The company operates a managed media company with production, distribution, development, and acquisition functions for film and television.

For more information, visit www.verdemediagroup.com , or connect with the company on Facebook . Twitter- @Verdemediagroup

DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS

The results described herein cannot be guaranteed. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions.

Verde Media Group, Inc., 310-954-9160 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading